The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has decided  to organise an India Pavilion during ‘CPhI India’ expected to be held in Mumbai in December this year.

Upbeat with the success of its first ever iPHEX global event organised exclusively by the Indian Industry last month, the council has chalked out its future promotional programme. As a part of this, the council is planning to organise India Pavilion at CPhI India to be held in Mumbai from December 3-5, 2013.

This year CPhI India 2013 is being held at the Bombay Convention and Exhibition Centre. The event organisers are hoping in to attract a large number of exhibitors from across the globe. More than 850+ exhibitors and around 25,000 attendees are expected to take part in the big event.

Last year CPhI-2012 held in Mumbai showcased India as a Global Pharma hub. It was a world class platform for the global pharmaceutical industry which strengthened India’s reputation as one of the most important pharma markets. CPhI India is regarded as largest pharmaceutical event in South Asia. It provides opportunity to interact and network with industry players from pharmaceutical ingredients, machinery, equipment and technology, contract services and biopharma solutions.

Last year the event witnessed 28,182 attendees from 95 countries across the globe. The event was held in seven exhibition halls spread over 55,000 square meters at the Bombay Exhibition Centre in Goregaon. There was a large representation of visitors from Bangladesh, China, Germany, Indonesia, Italy, Japan, Korea, Nepal, Nigeria, Russian Federation, Thailand, UAE, UK and USA.

For this year’s CPhI 2013 event, the council has already decided to secure 972 square meters of space to accommodate 108 stalls. “As a part our promotional activity, we are planning to organise India Pavalion at CPhI India in Mumbai this December. This is the seventh time such a big event happening in Mumbai and we want all our members to take part and gain the maximum from this opportunity,” says Dr PV Appaji, DG Pharmexcil.